Cargando…

The Influenza NS1 Protein: What Do We Know in Equine Influenza Virus Pathogenesis?

Equine influenza virus remains a serious health and potential economic problem throughout most parts of the world, despite intensive vaccination programs in some horse populations. The influenza non-structural protein 1 (NS1) has multiple functions involved in the regulation of several cellular and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barba, Marta, Daly, Janet M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039437/ https://www.ncbi.nlm.nih.gov/pubmed/27589809 http://dx.doi.org/10.3390/pathogens5030057

Ejemplares similares

Equine Crofton Weed (Ageratina spp.) Pneumotoxicity: What Do We Know and What Do We Need to Know?
por: Shapter, Frances Marie, et al.
Publicado: (2023)

Q&A: What do we know about influenza and what can we do about it?
por: Doherty, Peter C, et al.
Publicado: (2009)

The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know
por: Goldstein, David S.
Publicado: (2021)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

Immune responses to Tilapia lake virus infection: what we know and what we don’t know
por: Kembou-Ringert, Japhette E., et al.
Publicado: (2023)

Prevalence of gastrointestinal symptoms in patients with influenza, clinical significance, and pathophysiology of human influenza viruses in faecal samples: what do we know?
por: Minodier, Laetitia, et al.
Publicado: (2015)

Transmission of Equine Influenza Virus to English Foxhounds
por: Daly, Janet M., et al.
Publicado: (2008)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

The Optimisation of Pseudotyped Viruses for the Characterisation of Immune Responses to Equine Influenza Virus
por: Scott, Simon D., et al.
Publicado: (2016)

Emerging Influenza D Virus Threat: What We Know so Far!
por: Asha, Kumari, et al.
Publicado: (2019)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

The genetics of virus particle shape in equine influenza A virus
por: Elton, Debra, et al.
Publicado: (2013)

What can mathematical models bring to the control of equine influenza?
por: Daly, J M, et al.
Publicado: (2013)

Pulmonary Remodeling in Equine Asthma: What Do We Know about Mediators of Inflammation in the Horse?
por: Barton, Ann Kristin, et al.
Publicado: (2016)

Dengue Virus Glycosylation: What Do We Know?
por: Yap, Sally S. L., et al.
Publicado: (2017)

Viruses and celiac disease: what do we know ?
por: Cohen, Ramon, et al.
Publicado: (2023)

The use of equine influenza pseudotypes for serological screening
por: Scott, Simon, et al.
Publicado: (2012)

Correction for Osterholm et al., Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

Multimorbidity: What do we know? What should we do?
por: Navickas, Rokas, et al.
Publicado: (2016)

The convergent evolution of influenza A virus: Implications, therapeutic strategies and what we need to know
por: Low, Zheng Yao, et al.
Publicado: (2023)

2174: In silico prediction of NS1 structure and influenza A virus pathogenesis
por: Klonoski, Joshua, et al.
Publicado: (2018)

Inflammatory pathways in the pathogenesis of iatrogenic laryngotracheal stenosis: what do we know?
por: Davis, Ruth J., et al.
Publicado: (2020)

Equine Influenza Virus and Vaccines
por: Oladunni, Fatai S., et al.
Publicado: (2021)

Cerebrospinal fluid circulation: What do we know and how do we know it?
por: Khasawneh, Ahmad H, et al.
Publicado: (2018)

Metal wear particles: What we know, what we do not know, and why
por: Billi, Fabrizio, et al.
Publicado: (2009)

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know
por: Guasch, E., et al.
Publicado: (2018)

Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
por: Rai, Mahendra, et al.
Publicado: (2021)

Ticks and Tularemia: Do We Know What We Don't Know?
por: Zellner, Briana, et al.
Publicado: (2019)

Cardiac surgery and the coronavirus disease 2019 pandemic: What we know, what we do not know, and what we need to do
por: Bakaeen, Faisal G., et al.
Publicado: (2020)

Metabolic syndrome: is equine disease comparable to what we know in humans?
por: Ertelt, Antonia, et al.
Publicado: (2014)

COVID-19 virus and children: What do we know?
por: Morand, A., et al.
Publicado: (2020)

Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?
por: Gershman, Boris, et al.
Publicado: (2015)

What do we know about the origin of COVID-19 three years later?
por: Zapatero Gaviria, A., et al.
Publicado: (2023)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

The Mosquito Immune System and the Life of Dengue Virus: What We Know and Do Not Know
por: Mukherjee, Debica, et al.
Publicado: (2019)

Attenuation of the virulence of a recombinant influenza virus expressing the naturally truncated NS gene from an H3N8 equine influenza virus in mice
por: Na, Woonsung, et al.
Publicado: (2016)

Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know
por: Sun, Chuan-bin, et al.
Publicado: (2020)

Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bgmqnn982am46nrpcstgf832bg